The Discounted Cash Flow (DCF) valuation of Johnson & Johnson (JNJ) is 158.82 USD. With the latest stock price at 155.79 USD, the upside of Johnson & Johnson based on DCF is 1.9%.
Based on the latest price of 155.79 USD and our DCF valuation, Johnson & Johnson (JNJ) is a buy. buying JNJ stocks now will result in a potential gain of 1.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.7% | 6.8% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 105.76 - 318.69 | 158.82 |
| Upside | -32.1% - 104.6% | 1.9% |